These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27343068)

  • 1. DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.
    Bello L; Morgenroth LP; Gordish-Dressman H; Hoffman EP; McDonald CM; Cirak S;
    Neurology; 2016 Jul; 87(4):401-9. PubMed ID: 27343068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy.
    Zhang S; Qin D; Wu L; Li M; Song L; Wei C; Lu C; Zhang X; Hong S; Ma M; Wu S;
    Orphanet J Rare Dis; 2021 Apr; 16(1):188. PubMed ID: 33910603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype.
    Wang RT; Barthelemy F; Martin AS; Douine ED; Eskin A; Lucas A; Lavigne J; Peay H; Khanlou N; Sweeney L; Cantor RM; Miceli MC; Nelson SF
    Hum Mutat; 2018 Sep; 39(9):1193-1202. PubMed ID: 29907980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.
    Elhawary NA; Jiffri EH; Jambi S; Mufti AH; Dannoun A; Kordi H; Khogeer A; Jiffri OH; Elhawary AN; Tayeb MT
    Hum Genomics; 2018 Apr; 12(1):18. PubMed ID: 29631625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive genetic characteristics of dystrophinopathies in China.
    Ma P; Zhang S; Zhang H; Fang S; Dong Y; Zhang Y; Hao W; Wu S; Zhao Y
    Orphanet J Rare Dis; 2018 Jul; 13(1):109. PubMed ID: 29973226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic mutations and loss of ambulation in childhood-onset dystrophinopathy.
    Haber G; Conway KM; Paramsothy P; Roy A; Rogers H; Ling X; Kozauer N; Street N; Romitti PA; Fox DJ; Phan HC; Matthews D; Ciafaloni E; Oleszek J; James KA; Galindo M; Whitehead N; Johnson N; Butterfield RJ; Pandya S; Venkatesh S; Bhattaram VA
    Muscle Nerve; 2021 Feb; 63(2):181-191. PubMed ID: 33150975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.
    Okubo M; Noguchi S; Hayashi S; Nakamura H; Komaki H; Matsuo M; Nishino I
    Hum Genet; 2020 Feb; 139(2):247-255. PubMed ID: 31919629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China.
    Wang DN; Wang ZQ; Yan L; He J; Lin MT; Chen WJ; Wang N
    Neuromuscul Disord; 2017 Aug; 27(8):715-722. PubMed ID: 28318817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.
    Aartsma-Rus A; Fokkema I; Verschuuren J; Ginjaar I; van Deutekom J; van Ommen GJ; den Dunnen JT
    Hum Mutat; 2009 Mar; 30(3):293-9. PubMed ID: 19156838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
    Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
    Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expert recommendation: treatment of nonambulatory patients with Duchenne muscular dystrophy].
    Bernert G; Hahn A; Köhler C; Meyer S; Schara U; Schlachter K; Trollmann R; Walter MC
    Nervenarzt; 2021 Apr; 92(4):359-366. PubMed ID: 33215271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of genotype on age at loss of ambulation in individuals with Duchenne muscular dystrophy treated with corticosteroids: A single-center study of 555 patients.
    Zygmunt A; Wong B; Moon D; Horn P; Rathbun R; Lambert J; Bange J; Rybalsky I; Reebals L; Tian C
    Muscle Nerve; 2024 Nov; 70(5):1053-1061. PubMed ID: 39291879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.
    Ricotti V; Ridout DA; Pane M; Main M; Mayhew A; Mercuri E; Manzur AY; Muntoni F;
    J Neurol Neurosurg Psychiatry; 2016 Feb; 87(2):149-55. PubMed ID: 25733532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
    Aartsma-Rus A; Janson AA; van Ommen GJ; van Deutekom JC
    BMC Med Genet; 2007 Jul; 8():43. PubMed ID: 17612397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis.
    Murugan S; Chandramohan A; Lakshmi BR
    Indian J Med Res; 2010 Sep; 132():303-11. PubMed ID: 20847377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of deletions and duplications in the dystrophin (DMD) gene in a cohort of patients with Duchenne muscular dystrophy in Sri Lanka.
    Thakur N; Abeysekera G; Wanigasinghe J; Dissanayake VHW
    Neurol India; 2019; 67(3):714-715. PubMed ID: 31347541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene.
    Torella A; Zanobio M; Zeuli R; Del Vecchio Blanco F; Savarese M; Giugliano T; Garofalo A; Piluso G; Politano L; Nigro V
    PLoS One; 2020; 15(8):e0237803. PubMed ID: 32813700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?
    Yokota T; Duddy W; Echigoya Y; Kolski H
    Expert Opin Biol Ther; 2012 Sep; 12(9):1141-52. PubMed ID: 22650324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modifiers of respiratory function in Duchenne muscular dystrophy.
    Bello L; D'Angelo G; Villa M; Fusto A; Vianello S; Merlo B; Sabbatini D; Barp A; Gandossini S; Magri F; Comi GP; Pedemonte M; Tacchetti P; Lanzillotta V; Trucco F; D'Amico A; Bertini E; Astrea G; Politano L; Masson R; Baranello G; Albamonte E; De Mattia E; Rao F; Sansone VA; Previtali S; Messina S; Vita GL; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Vianello A; Bruno C; Hoffman EP; Morgenroth L; Gordish-Dressman H; McDonald CM; ; Pegoraro E
    Ann Clin Transl Neurol; 2020 May; 7(5):786-798. PubMed ID: 32343055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy].
    Takeshima Y
    Rinsho Byori; 2015 Oct; 63(10):1194-201. PubMed ID: 26897856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.